APOE4 alters the regional levels of numerous neuroimaging biomarkers across the Alzheimer's disease continuum

Abstract

Background: Carriers of the apolipoprotein E ε4 ( APOE4 ) allele are at an increased risk of developing Alzheimer's disease (AD) and display an earlier age of onset compared to non‐carriers who develop the disease.

The paper